Advanced Enzyme Technologies Cash Flow Annual

BSE: 540025 | NSE: ADVENZYMES | ISIN: INE837H01020 | Sector: Biotechnology & Drugs

266.30 -0.30 (-0.11%)Updated : 12 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-9.12	-10.55	6.01	-4.18
Net Changein Cash	14.53	-19.53	17.33	-170.94
Cash Taxes Paid	65.13	59.67	49.23	36.64
Net Income/ Starting Line	232.54	187.36	187.82	140.39
Total Cash Dividends Paid	-59.78	-59.03	-56.71	-12.54
Changesin Working Capital	-79.66	-71.89	-75.47	-36.94
Cashfrom Operating Activities	156.78	142.50	141.37	140.38
Cash Interest Paid	2.42	3.34	2.93	2.42
Cashfrom Financing Activities	-70.37	-72.54	-59.24	-25.80
Issuance( Retirement)of Stock Net	0.95	0.38	0.00	0.14
Depreciation/ Depletion	40.09	36.56	35.24	35.03
Other Investing Cash Flow Items Total	-21.90	-55.29	-22.34	-260.08
Capital Expenditures	-52.23	-33.81	-42.31	-38.11
period Type	-	-	-	-
Foreign Exchange Effects	2.25	-0.38	-0.15	12.66
Non- Cash Items	-36.20	-9.54	-6.23	1.91
Financing Cash Flow Items	-2.42	-3.34	-8.53	-9.22
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-74.13	-89.10	-64.65	-298.18